HUT41837A - Transformable genes of mammals causing tumoral metastasis - Google Patents

Transformable genes of mammals causing tumoral metastasis

Info

Publication number
HUT41837A
HUT41837A HU8667A HU6786A HUT41837A HU T41837 A HUT41837 A HU T41837A HU 8667 A HU8667 A HU 8667A HU 6786 A HU6786 A HU 6786A HU T41837 A HUT41837 A HU T41837A
Authority
HU
Hungary
Prior art keywords
tumoral
transformable
metastasis
genes
mammals
Prior art date
Application number
HU8667A
Other languages
English (en)
Hungarian (hu)
Inventor
Shelly Bernstein
Robert A Weinberg
Original Assignee
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst filed Critical Whitehead Biomedical Inst
Publication of HUT41837A publication Critical patent/HUT41837A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU8667A 1984-11-30 1985-11-26 Transformable genes of mammals causing tumoral metastasis HUT41837A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30
PCT/US1985/002323 WO1986003226A1 (en) 1984-11-30 1985-11-26 Transmissible, mammalian genes associated with tumor metastasis

Publications (1)

Publication Number Publication Date
HUT41837A true HUT41837A (en) 1987-05-28

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
HU8667A HUT41837A (en) 1984-11-30 1985-11-26 Transformable genes of mammals causing tumoral metastasis

Country Status (13)

Country Link
EP (1) EP0203970A1 (enrdf_load_stackoverflow)
JP (1) JPS62501399A (enrdf_load_stackoverflow)
AU (1) AU5197986A (enrdf_load_stackoverflow)
DK (1) DK359486A (enrdf_load_stackoverflow)
ES (1) ES8705043A1 (enrdf_load_stackoverflow)
FI (1) FI863095A0 (enrdf_load_stackoverflow)
GR (1) GR852864B (enrdf_load_stackoverflow)
HU (1) HUT41837A (enrdf_load_stackoverflow)
IL (1) IL77157A0 (enrdf_load_stackoverflow)
NO (1) NO863066L (enrdf_load_stackoverflow)
PT (1) PT81584B (enrdf_load_stackoverflow)
WO (1) WO1986003226A1 (enrdf_load_stackoverflow)
ZA (1) ZA859070B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
ES2164634T3 (es) * 1989-10-18 2002-03-01 Us Health Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
DE69630142D1 (de) * 1995-11-16 2003-10-30 Baylor College Medicine Verfahren zur identifizierung metastatischer sequenzen
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
WO1997025443A1 (en) * 1996-01-10 1997-07-17 The University Of Liverpool Metastasis inducing dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
WO1999022773A2 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
EP1062340A2 (en) 1998-03-13 2000-12-27 The Baylor College of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
FI863095L (fi) 1986-07-29
FI863095A7 (fi) 1986-07-29
DK359486D0 (da) 1986-07-29
ES8705043A1 (es) 1987-04-16
EP0203970A1 (en) 1986-12-10
AU5197986A (en) 1986-06-18
PT81584B (en) 1987-04-07
DK359486A (da) 1986-07-29
NO863066L (no) 1986-09-29
GR852864B (enrdf_load_stackoverflow) 1986-03-28
ZA859070B (en) 1986-07-30
IL77157A0 (en) 1986-04-29
JPS62501399A (ja) 1987-06-11
ES549438A0 (es) 1987-04-16
NO863066D0 (no) 1986-07-29
FI863095A0 (fi) 1986-07-29
PT81584A (en) 1985-12-01
WO1986003226A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
IL71691A (en) Production of interferon-ypsilon
GB8404726D0 (en) Production of methane-containing gas
ZA858523B (en) Mixtures of pigments
GB8531687D0 (en) Production of aromatics
GB8505503D0 (en) Production of fuels
GB8520977D0 (en) Production of aromatics
HUT41837A (en) Transformable genes of mammals causing tumoral metastasis
GB8522527D0 (en) Production of hydrocarbons
GB8423436D0 (en) Preparation of liposomes
GB8601132D0 (en) Production of paper
JPS56140893A (en) Production of gene modified microorganism
GB8512296D0 (en) Production of oxygenated hydrocarbons
GB2203752B (en) Manufacture of floating soap
GB8620985D0 (en) Determination of stability of floating structures
GB8520978D0 (en) Production of aromatics
GB2152505B (en) Production of melamine
JPS5711279A (en) Production of carpet tile
ZA851317B (en) Ester prodrugs of oxicams
GB8723398D0 (en) Production of beers
GB8418030D0 (en) Production of thin marble sheets
GB8512500D0 (en) Production of bodies-building elements
ZA854649B (en) Cyclic prodrugs of antiinflammatory oxicams
GB8401833D0 (en) Production of 1-alkoxy-alkyl esters
GB2155930B (en) Production of an acetyl compound
GB8608928D0 (en) Dewatering of air